Arjana Pradhan
About Arjana Pradhan
Arjana Pradhan is a Senior Manager of Regulatory Affairs at Kite Pharma, where she has worked since 2021. She has extensive experience in regulatory affairs within the pharmaceutical industry, having previously held positions at Amgen and Bionovo, among others.
Work at Kite Pharma
Arjana Pradhan has been serving as the Senior Manager of Regulatory Affairs at Kite Pharma since March 2021. In this role, she oversees regulatory strategies and compliance for the company's product portfolio. Prior to her current position, she worked as the Manager of Regulatory Affairs at Kite Pharma from 2019 to 2021. Her experience at Kite Pharma has contributed to her expertise in navigating complex regulatory landscapes within the pharmaceutical industry.
Previous Experience in Regulatory Affairs
Before joining Kite Pharma, Arjana Pradhan held the position of Senior Associate in US Regulatory Affairs - Oncology at Amgen from 2016 to 2019. Her role involved supporting regulatory submissions and interactions with health authorities. Additionally, she worked at Bionovo, Inc. as a Research Associate I from 2008 to 2010, where she gained foundational experience in the pharmaceutical sector. Her diverse background in regulatory affairs spans multiple therapeutic areas, including Oncology, Bone, and Inflammation.
Education and Expertise
Arjana Pradhan earned her Doctor of Philosophy (PhD) in Developmental Biology and Embryology from the University of California, San Diego, where she studied from 2010 to 2016. She also holds a Bachelor of Science (B.S.) degree in Biology and Chemistry from Salem College, completed from 2004 to 2008. Her educational background supports her professional focus on regulatory affairs within the pharmaceutical industry, equipping her with the necessary knowledge to navigate regulatory requirements effectively.
Research Experience
Arjana Pradhan has a history of research experience that complements her regulatory affairs career. She participated in an Undergraduate Research Fellowship at Mayo Clinic in 2007 and completed an HHMI Undergraduate Research Internship at North Carolina State University in 2006. Additionally, she undertook an Undergraduate Research Internship at Targacept, Inc. in 2005. These early research roles provided her with valuable insights into scientific inquiry and regulatory processes.